Skip to main content
Caplight Logo









Evida Biosciences

Evida Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://evidabiosciences.com

Last Round

Early Funding

Oct 11, 2024

Total Funding Raised

$42M

Company Overview

Evida Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Early Funding round in October 2024.

Evida Biosciences is a biotechnology company that focuses on the development of pharmaceutical ingredients and therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Evida Biosciences Comparables

Compare Evida Biosciences with similar companies based on industry and business-model similarity.

Evida Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Solstice Oncology
80%
Phanes Therapeutics
76%
SRT Therapeutics
74%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Evida Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingOct 11, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 11, 2024

    $42M raised in early funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

Evida Biosciences Filings

Explore SEC and related filing metadata, where available.

Evida Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Evida Biosciences's valuation, stock price, and market status.

Is Evida Biosciences a public or private company?

Evida Biosciences is a private company.

What is the current stock price of Evida Biosciences?

Evida Biosciences is a private company, so its shares have no public market price. Caplight tracks Evida Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Evida Biosciences worth (valuation)?

Valuation information for Evida Biosciences is not publicly available.

Can I buy Evida Biosciences stock?

Evida Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Evida Biosciences's last funding round?

Evida Biosciences's most recent funding round was Early Funding on October 11, 2024.

Who are the main investors in Evida Biosciences?

Investor information for Evida Biosciences is not publicly disclosed.

Will Evida Biosciences IPO soon?

No public IPO plans have been announced for Evida Biosciences.

How can I track Evida Biosciences secondary market activity?

Caplight tracks bids, offers, and trades in Evida Biosciences's shares on secondary markets.

Firmographic Details

HeadquartersSan Diego, California
Year Founded2024
Last FundingOct 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?